Kidney Cancer Drugs Global Market Report 2020

Dec 2019| TBR607A| TBRC (Publisher)

Report Highlights

Including: 1) By Type: Renal Cell Carcinoma (RCC), Transitional Cell Carcinoma (TCC) or Urothelial cell carcinoma (UCC) 2) By Product: Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient (Pazopanib), Avastin (Bevacizumab), Inlyta (Axitinib),, Torisel (Temsirolimus), Proleukin (Aldesleukin), Others 3) By End Users: Hospitals, Clinics, Research Center, Others
Covering: Bayer AG, Pfizer Inc, Novartis International AG, Exelixis, Inc, F. Hoffmann-La Roche Ag

Kidney Cancer Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global kidney cancer drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:
Where is the largest and fastest growing market for the kidney cancer drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Kidney Cancer Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope
Markets Covered: 1) By Type: Renal Cell Carcinoma (RCC), Transitional Cell Carcinoma (TCC) or Urothelial cell carcinoma (UCC) 2) By Product: Nexavar (Sorafenib), Sutent (Sunitinib), Afinitor (Everolimus), Votrient (Pazopanib), Avastin (Bevacizumab), Inlyta (Axitinib),, Torisel (Temsirolimus), Proleukin (Aldesleukin), Others 3) By End Users: Hospitals, Clinics, Research Center, Others

Companies Mentioned: Bayer AG, Pfizer Inc, Novartis International AG, Exelixis, Inc, F. Hoffmann-La Roche Ag

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

  • Table 1 : Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2 : Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
  • Table 3 : Global Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 4 : Global Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 5 : Global Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 6 : Global Kidney Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 7 : Global Kidney Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 8 : Asia-Pacific, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 9 : Asia-Pacific, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 10 : Asia-Pacific, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 11 : China, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 12 : China, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 13 : China, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 14 : India, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 15 : India, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 16 : India, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 17 : Japan, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 18 : Japan, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 19 : Japan, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 20 : Australia, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 21 : Australia, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 22 : Australia, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 23 : Indonesia, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 24 : Indonesia, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 25 : Indonesia, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 26 : South Korea, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 27 : South Korea, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 28 : South Korea, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 29 : Western Europe, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 30 : Western Europe, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 31 : Western Europe, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 32 : UK, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 33 : UK, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 34 : UK, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 35 : Germany, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 36 : Germany, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 37 : Germany, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 38 : France, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 39 : France, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 40 : France, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 41 : Eastern Europe, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 42 : Eastern Europe, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 43 : Eastern Europe, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 44 : Russia, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 45 : Russia, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 46 : Russia, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 47 : North America, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 48 : North America, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 49 : North America, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 50 : USA, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 51 : USA, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 52 : USA, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 53 : South America, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 54 : South America, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 55 : South America, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 56 : Brazil, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 57 : Brazil, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 58 : Brazil, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 59 : Middle East, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 60 : Middle East, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 61 : Middle East, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 62 : Africa, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 63 : Africa, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 64 : Africa, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Table 65 : Bayer AG Financial Performance
  • Table 66 : Pfizer Inc Financial Performance
  • Table 67 : Novartis International AG Financial Performance
  • Table 68 : Exelixis, Inc Financial Performance
  • Table 69 : F. Hoffmann-La Roche Ag Financial Performance
  • Figure 1 : Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2 : Global Forecast Market Growth, 2015-2022F, 2025F, 2030F, $ Billion
  • Figure 3 : Global Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 4 : Global Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 5 : Global Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 6 : Global Kidney Cancer Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 7 : Global Kidney Cancer Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 8 : Asia-Pacific, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 9 : Asia-Pacific, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 10 : Asia-Pacific, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 11 : China, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 12 : China, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 13 : China, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 14 : India, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 15 : India, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 16 : India, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 17 : Japan, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 18 : Japan, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 19 : Japan, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 20 : Australia, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 21 : Australia, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 22 : Australia, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 23 : Indonesia, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 24 : Indonesia, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 25 : Indonesia, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 26 : South Korea, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 27 : South Korea, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 28 : South Korea, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 29 : Western Europe, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 30 : Western Europe, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 31 : Western Europe, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 32 : UK, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 33 : UK, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 34 : UK, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 35 : Germany, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 36 : Germany, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 37 : Germany, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 38 : France, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 39 : France, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 40 : France, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 41 : Eastern Europe, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 42 : Eastern Europe, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 43 : Eastern Europe, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 44 : Russia, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 45 : Russia, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 46 : Russia, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 47 : North America, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 48 : North America, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 49 : North America, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 50 : USA, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 51 : USA, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 52 : USA, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 53 : South America, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 54 : South America, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 55 : South America, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 56 : Brazil, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 57 : Brazil, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 58 : Brazil, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 59 : Middle East, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 60 : Middle East, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 61 : Middle East, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 62 : Africa, Kidney Cancer Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 63 : Africa, Kidney Cancer Drugs Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 64 : Africa, Kidney Cancer Drugs Market, Segmentation By End Users, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • Figure 65 : Bayer AG Financial Performance
  • Figure 66 : Pfizer Inc Financial Performance
  • Figure 67 : Novartis International AG Financial Performance
  • Figure 68 : Exelixis, Inc Financial Performance
  • Figure 69 : F. Hoffmann-La Roche Ag Financial Performance

The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report